Interventional psychiatry could offer part of the solution to strained models of inpatient psychiatric care. Established in-clinic treatments such as ECT and TMS have demonstrated meaningful improvements for patients with Treatment Resistant Depression. Meanwhile, emerging home-based modalities (e.g., tDCS) offer a glimpse into a future of most accessible and cost-effective care.

The space of ambient AI scribing has become far more competitive. In this post, we unpack the current market context, the strategic implications of EHR native scribes, and what it will take for vendors to succeed in the next wave of clinical AI.

Market context – why do Private Hospital operators need to innovate? The private hospital market is under pressure. In Australia,...

Pathology is essential in modern healthcare. The healthcare system relies on pathology to ensure patients get correct diagnosis and...